Methamphetamine (METH) use is increasing in the United States. Striatal deficits in humans induced byMETH persist after detoxification and protracted abstinence and have been associated with impairment ofmotor tasks and learning. Our lab discovered that pharmacological blockade of the striatal neurokinin-1receptor (NK-1R) confers protection from METH to both dopamine (DA) terminals and striatal neurons. Thisinteresting and novel finding needs further investigation because it provides a therapeutic target for thetreatment of METH abuse. Our working hypothesis is that the excessive DA released in response to METH,interacts with substance P-containing striatal neurons. This in turn causes excessive release of substance P(SP), which then acts through NK-1Rs on cholinergic and somatostatin/NOS interneurons. In the latterneurons, nNOS is up-regulated and excessive NO produced. We suggest that the excessive NO is what iscausing the loss of DA-terminals and neuronal cell death in the striatum. This hypothesis will be tested by thefollowing specific aims:
Aim 1 : The purpose of this aim is to test the hypothesis that SP induces striatal injury in the presence ofMETH. To this end, the selective SP agonist GR73632 will be utilized to exacerbate METH-induced striatalneural damage.
Aim 2 : The purpose of this aim is to test the hypothesis that the striatal NK-1 Rs signal neural damage inthe presence of METH. To this end, the striatal NK-1 R-expressing cells will be destroyed with.the selectivetoxin SSP-saporin.
Aim 3 : The purpose of this aim is to test the hypothesis that SP modulates striatal NO production. To thisend, neurochemical and histological methods will be utilized to establish a connection between the striatalNK-1 Rs and the glutamate/NO neurotoxic cascade.The overall, long-term goal of these studies is to define the role of the NK-1Rs in the striatal injuryinduced by METH. The information gathered may prove valuable for the treatment of METH abuse and mayalso describe a role for this receptor in the striatum.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54NS041073-06A1
Application #
7349998
Study Section
Special Emphasis Panel (ZNS1-SRB-P (17))
Project Start
2006-09-01
Project End
2008-08-31
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
6
Fiscal Year
2006
Total Cost
$121,600
Indirect Cost
Name
Hunter College
Department
Type
DUNS #
620127915
City
New York
State
NY
Country
United States
Zip Code
10065
Kiprowska, Magdalena J; Stepanova, Anna; Todaro, Dustin R et al. (2017) Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis 1863:1157-1170
He, Huifang; Deng, Kangwen; Siddiq, Mustafa M et al. (2016) Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5. J Neurosci 36:3079-91
Siddiq, Mustafa M; Hannila, Sari S; Carmel, Jason B et al. (2015) Metallothionein-I/II Promotes Axonal Regeneration in the Central Nervous System. J Biol Chem 290:16343-56
Shivers, Kai-Yvonne; Nikolopoulou, Anastasia; Machlovi, Saima Ishaq et al. (2014) PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2. Biochim Biophys Acta 1842:1707-19
Huang, Qian; Wang, Hu; Perry, Seth W et al. (2013) Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons. J Biol Chem 288:12161-74
Huang, He; Wang, Hu; Figueiredo-Pereira, Maria E (2013) Regulating the ubiquitin/proteasome pathway via cAMP-signaling: neuroprotective potential. Cell Biochem Biophys 67:55-66
Hannila, Sari S; Siddiq, Mustafa M; Carmel, Jason B et al. (2013) Secretory leukocyte protease inhibitor reverses inhibition by CNS myelin, promotes regeneration in the optic nerve, and suppresses expression of the transforming growth factor-? signaling protein Smad2. J Neurosci 33:5138-51
Myeku, Natura; Wang, Hu; Figueiredo-Pereira, Maria E (2012) cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. Neurosci Lett 527:126-31
Metcalfe, M J; Huang, Q; Figueiredo-Pereira, M E (2012) Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP. Cell Death Dis 3:e326
Myeku, Natura; Figueiredo-Pereira, Maria E (2011) Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J Biol Chem 286:22426-40

Showing the most recent 10 out of 56 publications